HealthcareServices

Critical Limb Ischemia Market Growth Projection: Expected to Surpass $6 Billion by 2030 at 9% CAGR

February 23, 2026February 24, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the critical limb ischemia market from 2026–2035 with trusted insights from The Business Research Company

What total market size is anticipated for the Critical Limb Ischemia Market in 2030?

The critical limb ischemia market has experienced substantial expansion in recent years. Projections indicate it will increase from $3.89 billion in 2025 to $4.25 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.3%. The market’s historic growth is attributable to factors such as the high prevalence of peripheral artery disease, a rising incidence of diabetes, the growth of the aging population, a reliance on surgical revascularization, and delayed disease diagnosis.

The critical limb ischemia market is projected to experience substantial expansion over the coming years, reaching $6 billion by 2030, driven by a compound annual growth rate (CAGR) of 9.0%. This growth during the forecast period is propelled by factors such as progress in vascular devices, an increase in minimally invasive procedures, the establishment of more specialized vascular centers, heightened awareness surrounding limb preservation, and better access to diagnostic imaging. Key trends anticipated over the forecast period encompass a greater uptake of endovascular revascularization, enhanced utilization of drug-eluting devices, the development of more effective limb salvage treatment methods, the broadening of multidisciplinary vascular care, and an emphasis on prompt diagnosis and intervention.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9859&type=smp

What Drivers Are Influencing Production Trends In The Critical Limb Ischemia Market?

The future growth of the critical limb ischemia treatment market is expected to be propelled by increasing investments in healthcare infrastructure. This refers to the allocation of funds for the development, improvement, and maintenance of essential physical structures, facilities, and systems that support the delivery of healthcare services. Healthcare infrastructure investment plays a significant role in critical limb ischemia (CLI) treatment by providing the necessary facilities, equipment, and resources for effective diagnosis and treatment of the condition. For instance, in May 2023, a report published by the Office for National Statistics, a UK-based government department, showed that between 2022 and 2023, healthcare spending in the UK increased by 5.6%, which was higher than the 0.9% growth recorded in 2022. The total UK healthcare expenditure was approximately $317.63 billion (£292 billion) in 2023. Therefore, these increasing investments in healthcare infrastructure are driving the expansion of the critical limb ischemia treatment market.

Which Segment Groups Are Influencing The Critical Limb Ischemia Market?

The critical limb ischemia market covered in this report is segmented –

1) By Type: Devices, Drugs, Surgery

2) By Medication: Antihypertensive Agents, Antiplatelet Drugs, Antithrombotic Agents, Other Medications

3) By Application: Hospital, Clinic, Other Applications

Subsegments:

1) By Devices: Angioplasty Balloons, Stents, Catheters, Atherectomy Devices, Implantable Devices

2) By Drugs: Antiplatelet Agents, Vasodilators, Anticoagulants, Thrombolytics, Growth Factors And Cytokines

3) By Surgery: Bypass Surgery, Endarterectomy, Amputation, Revascularization Procedures

What Trends Are Projected To Support The Growth Of The Critical Limb Ischemia Market?

Leading companies in the critical limb ischemia (CLI) treatment market are developing technologically advanced products, such as dissolving stents, aimed at improving treatment outcomes for patients suffering from this severe form of peripheral artery disease. Dissolving stents, also referred to as bioresorbable stents, are engineered to provide temporary support to the affected artery before progressively dissolving once the vessel has healed. For example, in April 2024, Abbott Laboratories, a US-based medical device company, obtained approval from the Food and Drug Administration (FDA), a US-based federal agency, for its Esprit BTK Everolimus Eluting Resorbable Scaffold System. This dissolving stent is specifically designed for patients with chronic limb-threatening ischemia (CLTI) in arteries below the knee. This achievement signifies the first approval of a dissolving stent tailored for this condition in the United States. The stent, crafted from materials similar to dissolving sutures, is designed to gradually break down over approximately three years following implantation. It releases the immunosuppressive drug everolimus, which assists in preventing arteries from re-narrowing and supports overall vessel healing.

Who Are The Major Companies Operating In The Critical Limb Ischemia Market?

Major companies operating in the critical limb ischemia market are Medtronic Plc, Boston Scientific Corporation, Abbott Laboratories, LimFlow SA, Micro Medical Solutions, Cardiovascular Systems Inc., Shanghai MicroPort Medical (Group) Co Ltd., B. Braun SE, Teva Pharmaceutical Industries Ltd., Cook Medical, Philips, BD, Penumbra Inc., Cardinal Health Inc., Teleflex Incorporated, AngioDynamics Inc., Endologix Inc., Terumo Corporation, MicroPort Scientific, Silk Road Medical, LeMaitre Vascular Inc., Merit Medical Systems Inc., Shockwave Medical, Avinger, Biomerics LLC, Intact Vascular Inc., Bluegrass Vascular Technologies, PQ Bypass, Rex Medical, Aortica Corporation

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/critical-limb-ischemia-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Critical Limb Ischemia Market?

North America was the largest region in the critical limb ischemia treatment market in 2025. The regions covered in the critical limb ischemia market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Critical Limb Ischemia Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9859&type=smp

Browse Through More Reports Similar to the Global Critical Limb Ischemia Market 2026, By The Business Research Company

Myocardial Ischemia Market Report 2026

https://www.thebusinessresearchcompany.com/report/myocardial-ischemia-global-market-report

Acute Ischemic Stroke Diagnosis Market Report 2026

https://www.thebusinessresearchcompany.com/report/acute-ischemic-stroke-diagnosis-global-market-report

Acute Ischemic Stroke Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/acute-ischemic-stroke-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795